Xerys
Private equityParis · Seed–Late Stage
Investment thesis
Xerys is a fully independent private equity management company that puts the entrepreneur's vision at the heart of its approach. It aims to support the managers of its portfolio companies through every stage of growth, from venture capital to maturity, building close, constructive and proactive relationships to advise them on strategic decisions, trade-offs and value creation. This alignment of interests fosters trust between managers and investors and drives shared medium-term value creation. The firm focuses on two sectors — health and sustainable development — deploying investment tickets between roughly EUR 15M and EUR 90M.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 2 of 8 portfolio companiesBiotech ×2Healthtech ×1Medical Devices ×1
HQs:France×2
Investments · 8 tracked
founders shown can be your intro pathAdvanced BioDesign is a clinical-stage French biotechnology company developing small-molecule ALDH1 enzyme inhibitors to overcome drug resistance in chemotherapy-resistant cancers.
BiotechMedical Devices
Alzprotect is a biotech company developing therapeutic candidates for neurodegenerative diseases, including tauopathies such as Progressive Supranuclear Palsy (PSP) and Alzheimer's disease.
BiotechHealthtechLille, FR
Philippe Verwaerde(President & Chief Science Officer)
Company launching a line of regenerated polypropylene.
Frequently asked questions
- How many investments has Xerys made?
- Xerys has 8 tracked investments.
- What stage does Xerys invest at?
- Xerys invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Xerys's typical check size?
- Xerys typically writes checks of $16M – $97M.
- What sectors does Xerys focus on?
- Xerys focuses on Biotech, Circular Economy, Cleantech, Climate Tech, Healthtech, Medical Devices.
- Where is Xerys located?
- Xerys is headquartered in Paris, FR.
- Does Xerys lead rounds?
- Yes, Xerys leads investment rounds.
Similar investors
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Seventure Partners is a European venture capital firm, founded in 1997 and a subsidiary of Natixis Investment Managers, investing in digital technologies and life sciences companies with strong growth potential.
Starquest Capital is an impact-focused investment firm dedicated to financing disruptive green technologies that reduce emissions, protect biodiversity, and enable climate adaptation. It operates several thematic funds: a Biodiversity Fund, a CCR-Fund for climate adaptation and disaster prevention, and a Protect fund for decarbonization technologies.
Orbia Ventures is the corporate venture capital arm of Orbia, backing startups focused on climate technology, decarbonization, sustainability, circular economy, food security, water infrastructure, data access, and energy storage.
INP Capital is a global investment firm that invests across the full company life cycle, from early stage to pre-IPO, seeking to identify and back emerging technology companies as they scale toward unicorn status.